SEC Form 4 · accession 0000899243-16-023868

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Jun 27, 2016

Accepted (ET)

Jun 29, 2016 · 6:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 27, 2016	P	107,143	$14.00	A	157,009	D
Common Stock^F1	Jun 27, 2016	C	799,915	—	A	956,924	D
Common Stock^F2	Jun 27, 2016	C	208,705	—	A	1,165,629	D
Common Stock^F3	Jun 27, 2016	C	310,548	—	A	1,476,177	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series D Convertible Preferred Stock^F1	—	Jun 27, 2016	C	2,981,019	D	—	—	Common Stock	799,915	D
Series SRN Convertible Preferred Stock^F2	—	Jun 27, 2016	C	777,777	D	—	—	Common Stock	208,705	D
Series E Convertible Preferred Stock^F3	—	Jun 27, 2016	C	781,322	D	—	—	Common Stock	310,548	D

F12,981,019 outstanding shares of Series D Convertible Preferred Stock automatically converted into 799,915 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.
F2777,777 outstanding shares of Series SRN Convertible Preferred Stock automatically converted into 208,705 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.
F3781,322 outstanding shares of Series E Convertible Preferred Stock automatically converted into 310,548 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.